Omada Health, Inc. (NASDAQ:OMDA) Receives $24.50 Consensus PT from Analysts

Key Points

• Omada Health, Inc. has been rated as a "Moderate Buy" by analysts, with seven out of nine recommending a buy and two a hold, targeting an average price of $24.50.
• The company recently missed earnings expectations, reporting a loss of ($0.22) EPS against a consensus estimate of ($0.15) but exceeded revenue expectations with $61.37 million for the quarter.
• Significant institutional interest has been noted, with several large investors purchasing new positions in Omada Health during the second quarter, including Perceptive Advisors LLC with an investment of approximately $44.4 million.

Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) has been given an average rating of "Moderate Buy" by the nine research firms that are currently covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $24.50.

Several research firms have weighed in on OMDA. Baird R W upgraded Omada Health to a "hold" rating in a research report on Friday, September 5th. Wall Street Zen upgraded Omada Health to a "hold" rating in a report on Monday, June 16th. Evercore ISI increased their price objective on shares of Omada Health from $21.00 to $23.00 and gave the stock an "outperform" rating in a research report on Wednesday, July 9th. Barclays lifted their price target on Omada Health from $21.00 to $24.00 and gave the stock an "overweight" rating in a report on Friday, August 8th. Finally, JPMorgan Chase & Co. began coverage on Omada Health in a research note on Tuesday, July 1st. They issued an "overweight" rating and a $19.00 target price on the stock.

Institutional Trading of Omada Health

Institutional investors and hedge funds have recently modified their holdings of the company. Raymond James Financial Inc. bought a new stake in Omada Health during the second quarter worth approximately $32,000. Ilex Capital Partners UK LLP acquired a new stake in shares of Omada Health during the second quarter worth $201,000. Sandia Investment Management LP acquired a new stake in Omada Health during the 2nd quarter valued at approximately $366,000. XTX Topco Ltd acquired a new position in shares of Omada Health in the second quarter worth about $414,000. Finally, Walleye Capital LLC acquired a new position in shares of Omada Health during the 2nd quarter worth about $458,000.

Omada Health Price Performance

OMDA traded up $0.20 during trading on Friday, hitting $22.96. The stock had a trading volume of 88,697 shares, compared to its average volume of 608,005. The company has a 50 day simple moving average of $20.51. Omada Health has a 12 month low of $14.14 and a 12 month high of $28.40.

Omada Health (NASDAQ:OMDA - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The company reported ($0.22) EPS for the quarter, missing analysts' consensus estimates of ($0.15) by ($0.07). The business had revenue of $61.37 million for the quarter, compared to analysts' expectations of $55.17 million. Omada Health has set its FY 2025 guidance at EPS.

About Omada Health

Omada's mission is to bend the curve. Our hope is that, one day, tomorrow's epidemiologists will notice a bend in disease curves, wonder what might be happening, and conclude that part of that impact has been Omada. As part of that mission, we strive to inspire and enable people to make lasting health changes on their own terms.